journal article Open Access Jun 27, 2024

Integrated surveillance systems for antibiotic resistance in a One Health context: a scoping review

View at Publisher Save 10.1186/s12889-024-19158-6
Abstract
Abstract
Background
Antibiotic resistance (ABR) has emerged as a major threat to health. Properly informed decisions to mitigate this threat require surveillance systems that integrate information on resistant bacteria and antibiotic use in humans, animals, and the environment, in line with the One Health concept. Despite a strong call for the implementation of such integrated surveillance systems, we still lack a comprehensive overview of existing organizational models for integrated surveillance of ABR. To address this gap, we conducted a scoping review to characterize existing integrated surveillance systems for ABR.

Methods
The literature review was conducted using the PRISMA guidelines. The selected integrated surveillance systems were assessed according to 39 variables related to their organization and functioning, the socio-economic and political characteristics of their implementation context, and the levels of integration reached, together with their related outcomes. We conducted two distinct, complementary analyses on the data extracted: a descriptive analysis to summarize the characteristics of the integrated surveillance systems, and a multiple-correspondence analysis (MCA) followed by a hierarchical cluster analysis (HCA) to identify potential typology for surveillance systems.

Results
The literature search identified a total of 1330 records. After the screening phase, 59 references were kept from which 14 integrated surveillance systems were identified. They all operate in high-income countries and vary in terms of integration, both at informational and structural levels. The different systems combine information from a wide range of populations and commodities -in the human, animal and environmental domains, collection points, drug-bacterium pairs, and rely on various diagnostic and surveillance strategies. A variable level of collaboration was found for the governance and/or operation of the surveillance activities. The outcomes of integration are poorly described and evidenced. The 14 surveillance systems can be grouped into four distinct clusters, characterized by integration level in the two dimensions. The level of resources and regulatory framework in place appeared to play a major role in the establishment and organization of integrated surveillance.

Conclusions
This study suggests that operationalization of integrated surveillance for ABR is still not well established at a global scale, especially in low and middle-income countries and that the surveillance scope is not broad enough to obtain a comprehensive understanding of the complex dynamics of ABR to appropriately inform mitigation measures. Further studies are needed to better characterize the various integration models for surveillance with regard to their implementation context and evaluate the outcome of these models.
Topics

No keywords indexed for this article. Browse by subject →

References
109
[1]
O’Neill J. Tackling drug-resistant infections globally: final report and recommendations. 2016.
[2]
World Bank. Drug-resistant infections: a threat to our economic future. Washington, DC: World Bank; 2017. 10.1596/26707
[3]
Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis

Christopher J L Murray, Kevin Shunji Ikuta, Fablina Sharara et al.

The Lancet 2022 10.1016/s0140-6736(21)02724-0
[4]
Understanding the mechanisms and drivers of antimicrobial resistance

Alison H Holmes, Luke S P Moore, Arnfinn Sundsfjord et al.

The Lancet 2016 10.1016/s0140-6736(15)00473-0
[6]
Diallo OO, Baron SA, Abat C, Colson P, Chaudet H, Rolain J-M. Antibiotic resistance surveillance systems: a review. J Glob Antimicrob Resist. 2020;23:430–8. 10.1016/j.jgar.2020.10.009
[7]
Rolain J-M, Abat C, Jimeno M-T, Fournier P-E, Raoult D. Do we need new antibiotics? Clin Microbiol Infect. 2016;22:408–15. 10.1016/j.cmi.2016.03.012
[8]
Perez F, Villegas MV. The role of surveillance systems in confronting the global crisis of antibiotic-resistant bacteria. Curr Opin Infect Dis. 2015;28:375–83. 10.1097/qco.0000000000000182
[9]
Robinson TP, Bu DP, Carrique-Mas J, Fèvre EM, Gilbert M, Grace D, et al. Antibiotic resistance is the quintessential one health issue. Trans R Soc Trop Med Hyg. 2016;110:377–80. 10.1093/trstmh/trw048
[10]
Sirichokchatchawan W, Apiwatsiri P, Pupa P, Saenkankam I, Khine NO, Lekagul A, et al. Reducing the risk of transmission of critical antimicrobial resistance determinants from contaminated pork products to humans in South-East Asia. Front Microbiol. 2021;12:689015. 10.3389/fmicb.2021.689015
[11]
Hernando-Amado S, Coque TM, Baquero F, Martínez JL. Defining and combating antibiotic resistance from one health and global health perspectives. Nat Microbiol. 2019;4:1432–42. 10.1038/s41564-019-0503-9
[12]
Antibiotic Resistance: One Health One World Outlook

Bilal Aslam, Mohsin Khurshid, Muhammad Imran Arshad et al.

Frontiers in Cellular and Infection Microbiology 2021 10.3389/fcimb.2021.771510
[13]
Adisasmito WB, Almuhairi S, Behravesh CB, Bilivogui P, Bukachi SA, Casas N, et al. One Health: a new definition for a sustainable and healthy future. PLoS Pathog. 2022;18:e1010537. 10.1371/journal.ppat.1010537
[14]
Evidence needed for antimicrobial resistance surveillance systems

Cécile Aenishaenslin, Barbara Häsler, André Ravel et al.

Bulletin of the World Health Organization 2019 10.2471/blt.18.218917
[15]
CIPARS. Canadian Integrated Program for Antimicrobial Resistance Surveillance (CIPARS) 2018 Design and Methods. Guelph: Public Health Agency of Canada; 2020. p. 1-57. https://publications.gc.ca/site/eng/9.894244/publication.html. Accessed July 2023.
[16]
CDC. Covid-19 U.S. Impact on antimicrobial resistance. 2022.
[17]
DANMAP. Use of antimicrobial agents and occurrence of antimicrobial resistance in bacteria from food animals, food and humans in Denmark. 2020.
[19]
WHO. Global antimicrobial resistance and use surveillance system (GLASS). 2021.
[20]
WHO. Global action plan on antimicrobial resistance. 2017.
[21]
Rüegg SR, Antoine-Moussiaux N, Aenishaenslin C, Alban L, Bordier M, Bennani H, et al. Guidance for evaluating integrated surveillance of antimicrobial use and resistance. CABI One Heal. 2022;2022:ohcs20220007. 10.1079/cabionehealth.2022.0007
[22]
A One Health approach to antimicrobial resistance surveillance: is there a business case for it?

Kevin Queenan, Barbara Häsler, Jonathan Rushton

International Journal of Antimicrobial Agents 2016 10.1016/j.ijantimicag.2016.06.014
[23]
Bordier M, Uea-Anuwong T, Binot A, Hendrikx P, Goutard FL. Characteristics of one health surveillance systems: a systematic literature review. Prev Vet Med. 2020;181:10456. 10.1016/j.prevetmed.2018.10.005
[24]
An analysis of national action plans on antimicrobial resistance in Southeast Asia using a governance framework approach

Alvin Qijia Chua, Monica Verma, Li Yang Hsu et al.

The Lancet Regional Health - Western Pacific 2021 10.1016/j.lanwpc.2020.100084
[25]
Gandra S, Alvarez-Uria G, Turner P, Joshi J, Limmathurotsakul D, Rogier H, et al. Antimicrobial Resistance Surveillance in Low- and Middle- Income Countries: Progress and Challenges in Eight South Asian and Southeast Asian Countries. Am Soc Microbiol. 2020;33:1–29.
[26]
Systematic review of surveillance systems for AMR in Africa

Obiageli Jovita Okolie, Uzoma Igwe, Sanda Umar Ismail et al.

Journal of Antimicrobial Chemotherapy 2022 10.1093/jac/dkac342
[27]
Varona OM, Chaintarli K, Muller-Pebody B, Anjum MF, Eckmanns T, Norström M, et al. Monitoring antimicrobial resistance and drug usage in the human and livestock sector and foodborne antimicrobial resistance in six European countries. Infect Drug Resist. 2020;13:957–93. 10.2147/idr.s237038
[28]
Sandberg M, Hesp A, Aenishaenslin C, Bordier M, Bennani H, Bergwerff U, et al. Assessment of evaluation tools for integrated surveillance of antimicrobial use and resistance based on selected case studies. Front Vet Sci. 2021;8:8. 10.3389/fvets.2021.620998
[29]
Bennani H, Cornelsen L, Stärk KDC, Häsler B. Evaluating integrated surveillance for antimicrobial use and resistance in England: a qualitative study. Front Vet Sci. 2021;8:743857. 10.3389/fvets.2021.743857
[30]
Stärk KDC, Arroyo Kuribreña M, Dauphin G, Vokaty S, Ward MP, Wieland B, et al. One Health surveillance - More than a buzz word? Prev Vet Med. 2015;120:124–30. 10.1016/j.prevetmed.2015.01.019
[31]
Updated methodological guidance for the conduct of scoping reviews

Micah D.J. Peters, Casey Marnie, Andrea C. Tricco et al.

JBI Evidence Synthesis 2020 10.11124/jbies-20-00167
[32]
Guidance for conducting systematic scoping reviews

Micah D.J. Peters, Christina M. Godfrey, Hanan Khalil et al.

International Journal of Evidence-Based Healthcare 2015 10.1097/xeb.0000000000000050
[33]
Bordier M, Delavenne C, Nguyen DTT, Goutard FL, Hendrikx P. One health surveillance: a matrix to evaluate multisectoral collaboration. Front Vet Sci. 2019;6:1509. 10.3389/fvets.2019.00109
[34]
Evaluating the Integration of One Health in Surveillance Systems for Antimicrobial Use and Resistance: A Conceptual Framework

Cécile Aenishaenslin, Barbara Häsler, André Ravel et al.

Frontiers in Veterinary Science 2021 10.3389/fvets.2021.611931
[35]
Whatever happened to qualitative description?

Margarete Sandelowski

Research in Nursing &amp; Health 2000 10.1002/1098-240x(200008)23:4<334::aid-nur9>3.0.co;2-g
[36]
Maugeri A, Barchitta M, Puglisi F, Agodi A. Socio-economic, governance and health indicators shaping antimicrobial resistance: an ecological analysis of 30 european countries. Global Health. 2023;19:12. 10.1186/s12992-023-00913-0
[37]
FAO, WHO, WHOA. Global Database for the Tripartite Antimicrobial Resistance (AMR) Country Self- assessment Survey (TrACSS) 2023. Available at amrcountryprogress.org. Accessed July 2023.
[38]
World Bank. World Bank Open Data. 2023. Available at https://data.worldbank.org. Accessed July 2023.
[39]
FAO. FAOSTAT online database. 2023. Available at https://www.fao.org/faostat. Accessed July 2023.
[40]
Berezowski J, Akkina J, Vilas VD, DeVore K, Dórea FC, Dupuy CDC, et al. Is There a Need for One Health Surveillance (OHS)?. Online J Pub Health Inform. 2016;8(1):e11. 10.5210/ojphi.v8i1.6411
[41]
Bennani H, Cornelsen L, Stärk KDC, Häsler B. Characterisation and mapping of the surveillance system for antimicrobial resistance and antimicrobial use in the United Kingdom. Vet Rec. 2021;188(7):e10. 10.1002/vetr.10
[42]
Dutil L, Irwin R, Finley R, Ng LK, Avery B, Boerlin P, et al. Ceftiofur resistance in Salmonella enterica serovar Heidelberg from chicken meat and humans. Canada Emerg Infect Dis. 2010;16:48–54. 10.3201/eid1601.090729
[43]
Goossens H, Coenen S, Costers M, De Corte S, De Sutter A, Gordts B, et al. Achievements of the Belgian Antibiotic Policy Coordination Committee (BAPCOC). Euro Surveill. 2008;13(46):19036. 10.2807/ese.13.46.19036-en
[44]
BELMAP. One Health report on antibiotic use and resistance. 2020.
[45]
Mader R, Jarrige N, Haenni M, Bourély C, Madec JY, Amat JP. OASIS evaluation of the French surveillance network for antimicrobial resistance in diseased animals (RESAPATH): success factors underpinning a well-performing voluntary system. Epidemiol Infect. 2020;149:e104. 10.1017/s0950268821000856
[46]
Collineau L, Bourély C, Rousset L, Berger-Carbonne A, Ploy M-C, Pulcini C, et al. Towards one health surveillance of antibiotic resistance: characterisation and mapping of existing programmes in humans, animals, food and the environment in France, 2021. Eurosurveillance. 2023;28:28. 10.2807/1560-7917.es.2023.28.22.2200804
[47]
ONERBA. Annual report. 2018.
[48]
Gu Y, Fujitomo Y, Ohmagari N. Outcomes and future prospect of japan’s national action plan on antimicrobial resistance (2016–2020). Antibiot (Basel, Switzerland). 2021;10(11):1293.
[49]
Jindai K, McLellan RT, Takakura S, Noda H, Miyake K. Nippon AMR one health report: the first step towards multisectoral collaboration. Lancet Infect Dis. 2018;18:1179–80. 10.1016/s1473-3099(18)30566-8
[50]
Prins JM, Degener JE, de Neeling AJ, Gyssens IC. Experiences with the dutch working party on antibiotic policy (SWAB). Euro Surveill Bull Eur sur les Mal Transm = Eur Commun Dis Bull. 2008;13:19037.

Showing 50 of 109 references

Metrics
26
Citations
109
References
Details
Published
Jun 27, 2024
Vol/Issue
24(1)
License
View
Funding
Agence Nationale de la Recherche Award: ANR-21-AAMR-0002-03
Canadian Institutes of Health Research Award: 3468277
Cite This Article
Léo Delpy, Chloe Clifford Astbury, Cécile Aenishaenslin, et al. (2024). Integrated surveillance systems for antibiotic resistance in a One Health context: a scoping review. BMC Public Health, 24(1). https://doi.org/10.1186/s12889-024-19158-6
Related

You May Also Like